Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Garden, Adam S."" wg kryterium: Autor


Tytuł :
Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors.
Autorzy :
Aggarwal P; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mott FE; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lu C; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Chambers MS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sturgis EM; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Shete S; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Cancer [Cancer] 2021 Dec 01; Vol. 127 (23), pp. 4470-4480. Date of Electronic Publication: 2021 Aug 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Proton Image-guided Radiation Assignment for Therapeutic Escalation via Selection of locally advanced head and neck cancer patients [PIRATES]: A Phase I safety and feasibility trial of MRI-guided adaptive particle radiotherapy.
Autorzy :
van Dijk LV; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Preston KE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Qing Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Spiotto MT; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lee A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Langendijk JA; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2021 Nov 11; Vol. 32, pp. 35-40. Date of Electronic Publication: 2021 Nov 11 (Print Publication: 2022).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: Large, single-institution, modern cohort study.
Autorzy :
Diao K; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Nguyen TP; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Moreno AC; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Reddy JP; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Garden AS; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Wang CH; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Tung S; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Wang C; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Wang XA; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Shah SJ; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Lee A; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Spiotto MT; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Su SY; Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Ferrarotto R; Department of Thoracic Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Phan J; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2021 Nov; Vol. 43 (11), pp. 3331-3344. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Head and Neck Neoplasms*/radiotherapy
Radiosurgery*
Re-Irradiation*
Cohort Studies ; Humans ; Neoplasm Recurrence, Local/radiotherapy ; Retrospective Studies
Czasopismo naukowe
Tytuł :
The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry.
Autorzy :
van Dijk LV; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ferrarotto R; Division of Cancer Medicine, Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
McCoy LA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; College of Medicine, University of Houston, Houston, Texas.
Sharafi CS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Jones E; Texas Undergraduate Medical Academy, Prairie View A&M University, Prairie View, Texas.
Steele K; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Texas Undergraduate Medical Academy, Prairie View A&M University, Prairie View, Texas.
Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lai SY; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Myers JN; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hutcheson KA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Corporate Authors :
MD Anderson Symptom Working Group
Źródło :
Cancer [Cancer] 2021 Jul 15; Vol. 127 (14), pp. 2453-2464. Date of Electronic Publication: 2021 Mar 31.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia.
Autorzy :
Cao J; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States; Department of Radiation Oncology, The Shanxi Cancer Hospital and Institute, Affiliated Hospital of Shanxi Medical University, Shanxi, China.
Zhang X; Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, United States. Electronic address: .
Jiang B; Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, United States.
Chen J; Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, United States.
Wang X; Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, United States.
Wang L; Experimental Radiation Oncology, and The University of Texas MD Anderson Cancer Center, Houston, United States.
Sahoo N; Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, United States.
Zhu XR; Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, United States.
Ye R; Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, United States.
Blanchard P; Department of Radiotherapy, Gustave Roussy Cancer Campus, Villejuif, France.
Garden AS; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Fuller CD; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Gunn GB; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Frank SJ; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States. Electronic address: .
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Jul; Vol. 160, pp. 32-39. Date of Electronic Publication: 2021 Apr 08.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Oropharyngeal Neoplasms*/radiotherapy
Proton Therapy*/adverse effects
Radiotherapy, Intensity-Modulated*/adverse effects
Xerostomia*/epidemiology
Xerostomia*/etiology
Xerostomia*/prevention & control
Humans ; Radiotherapy Dosage ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer.
Autorzy :
Aggarwal P; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Mott FE; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston.
Duvall A; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Sturgis EM; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston.
Shete S; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston.; Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston.
Pokaż więcej
Źródło :
JAMA otolaryngology-- head & neck surgery [JAMA Otolaryngol Head Neck Surg] 2021 Jul 01; Vol. 147 (7), pp. 615-623.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cancer Survivors*
Patient Reported Outcome Measures*
Oropharyngeal Neoplasms/*therapy
Speech Disorders/*epidemiology
Voice Disorders/*epidemiology
Adult ; Aged ; Aged, 80 and over ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Surveys and Questionnaires ; Texas/epidemiology
Czasopismo naukowe
Tytuł :
The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer.
Autorzy :
Kish JA; H. Lee Moffitt Cancer Center & Research Institute, United States of America. Electronic address: .
Zhang Q; NRG Oncology Statistics and Data Management Center, United States of America.
Langer CJ; University of Pennsylvania, United States of America.
Nguyen-Tân PF; Centre Hospitalier de l'Université de Montréal-Notre Dame, Canada.
Rosenthal DI; University of Texas-MD Anderson Cancer Center, United States of America.
Weber RS; University of Texas-MD Anderson Cancer Center, United States of America.
List MA; University of Chicago Comprehensive Cancer Center, United States of America.
Wong SJ; Medical College of Wisconsin, United States of America.
Garden AS; University of Texas-MD Anderson Cancer Center, United States of America.
Hu K; New York University Langone, United States of America.
Trotti AM; H. Lee Moffitt Cancer Center & Research Institute, United States of America.
Bonner JA; University of Alabama at Birmingham, United States of America.
Jones CU; Radiological Associates of Sacramento, United States of America.
Yom SS; University of California San Francisco, United States of America.
Thorstad W; Washington University, United States of America.
Schultz CJ; Medical College of Wisconsin, United States of America.
Ridge JA; Fox Chase Cancer Center, United States of America.
Shenouda G; McGill University, Canada.
Harris J; NRG Oncology Statistics and Data Management Center, United States of America.
Le QT; Stanford University, United States of America.
Pokaż więcej
Źródło :
Journal of geriatric oncology [J Geriatr Oncol] 2021 Jul; Vol. 12 (6), pp. 937-944. Date of Electronic Publication: 2021 Apr 02.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Chemoradiotherapy*
Head and Neck Neoplasms*/radiotherapy
Aged ; Humans ; Prognosis ; Proportional Hazards Models ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer.
Autorzy :
Smith GL; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fu S; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ning MS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nguyen DK; University of California Riverside School of Medicine, Riverside, CA, USA.
Busse PM; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Foote RL; Department of Radiation Oncology, Mayo Clinic and Mayo Clinic School of Medicine and Science, Rochester, MN, USA.
Garden AS; Willis-Knighton Proton Therapy Center, Shreveport, LA, USA.
Gunn GB; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chronowski GM; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shah SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mayo LL; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reddy JP; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Snider JW 3rd; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA.
Patel SH; Department of Radiation Oncology, Mayo Clinic and Mayo Clinic School of Medicine and Science, Phoenix, AZ, USA.
Katz SR; Willis-Knighton Proton Therapy Center, Shreveport, LA, USA.
Lin A; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Mohammed N; Northwestern Medicine Chicago Proton Center, Warrenville, IL, USA.
Dagan R; Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA.
Lee NY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Rosenthal DI; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
International journal of particle therapy [Int J Part Ther] 2021 Jun 25; Vol. 8 (1), pp. 319-327. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Proton Therapy for Major Salivary Gland Cancer: Clinical Outcomes.
Autorzy :
Hanania AN; Department of Radiation Oncology, Baylor College of Medicine, Houston, TX, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zhang X; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Moreno A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chronowski G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shah S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ausat N; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hanna E; Department of Head and Neck Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; Department of Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
International journal of particle therapy [Int J Part Ther] 2021 Jun 25; Vol. 8 (1), pp. 261-272. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of Life.
Autorzy :
Sherry AD; Vanderbilt University School of Medicine, Nashville, TN, USA.
Pasalic D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gross ND; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gillison ML; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
El-Naggar AK; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
International journal of particle therapy [Int J Part Ther] 2021 Jun 25; Vol. 8 (1), pp. 234-247. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Patient-Reported Outcomes after Intensity-Modulated Proton Therapy for Oropharynx Cancer.
Autorzy :
Bahig H; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Centre Hospitalier de l'Université de Montréal, Montreal, Canada.
Gunn BG; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ye R; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hutcheson K; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reddy JP; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ng SP; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Peter MacCallum Cancer Center, Melbourne, Australia.
Gross ND; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sturgis EM; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gillison M; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
International journal of particle therapy [Int J Part Ther] 2021 Jun 25; Vol. 8 (1), pp. 213-222. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer.
Autorzy :
Thaker NG; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Arizona Oncology, The US Oncology Network, Tucson, AZ, USA.
Boyce-Fappiano D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ning MS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pasalic D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Guzman A; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Smith G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Holliday EB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Incalcaterra J; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shaitelman SF; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Blanchard P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Feeley TW; Harvard Business School, Boston, MA, USA.
Kaplan RS; Harvard Business School, Boston, MA, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
International journal of particle therapy [Int J Part Ther] 2021 Jun 25; Vol. 8 (1), pp. 374-382. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience.
Autorzy :
Gunn GB; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ye R; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ausat N; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dahlstrom KR; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reddy JP; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shah SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mayo LL; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chun SG; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chronowski GM; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Moreno AC; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Myers JN; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hanna EY; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Esmaeli B; Ophthalmic Plastic Surgery, Department of Plastic Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gillison ML; Department of Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; Department of Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hutcheson KA; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chambers MS; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ginsberg LE; Department of Neuroradiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
El-Naggar AK; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zhu XR; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
International journal of particle therapy [Int J Part Ther] 2021 Jun 25; Vol. 8 (1), pp. 108-118. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy.
Autorzy :
Taku N; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Wang L; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Spiotto MT; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Chronowski G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Shah SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Mayo LL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Gross ND; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; Department of Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zhu XR; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zhang X; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. .
Pokaż więcej
Źródło :
Current treatment options in oncology [Curr Treat Options Oncol] 2021 Jun 04; Vol. 22 (6), pp. 54. Date of Electronic Publication: 2021 Jun 04.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Bioelectrical impedance analysis as a quantitative measure of sarcopenia in head and neck cancer patients treated with radiotherapy.
Autorzy :
Grossberg AJ; Department of Radiation Medicine, Brenden Colson Center for Pancreatic Care, Cancer Early Detection Advanced Research Center, Oregon Health & Science University, Portland, USA. Electronic address: .
Rock CD; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, USA.
Edwards J; School of Medicine, Oregon Health & Science University, Portland, USA.
Mohamed ASR; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA.
Ruzensky D; Department of Clinical Nutrition, MD Anderson Cancer Center, Houston, USA.
Currie A; Department of Clinical Nutrition, MD Anderson Cancer Center, Houston, USA.
Rosemond P; Department of Clinical Nutrition, MD Anderson Cancer Center, Houston, USA.
Phan J; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA.
Gunn GB; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA.
Frank SJ; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA.
Morrison WH; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA.
Garden AS; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA.
Fuller CD; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA.
Rosenthal DI; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA. Electronic address: .
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Jun; Vol. 159, pp. 21-27. Date of Electronic Publication: 2021 Mar 15.
Typ publikacji :
Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Head and Neck Neoplasms*/complications
Head and Neck Neoplasms*/metabolism
Head and Neck Neoplasms*/radiotherapy
Sarcopenia*/diagnosis
Sarcopenia*/etiology
Body Composition ; Body Mass Index ; Electric Impedance ; Female ; Humans ; Male ; Muscle, Skeletal
Czasopismo naukowe
Tytuł :
Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses.
Autorzy :
Abdelmeguid AS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Teeramatwanich W; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Roberts DB; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Amit M; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ferraroto R; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Glisson BS; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kupferman ME; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Su SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Raza SM; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
DeMonte F; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Cancer [Cancer] 2021 Jun 01; Vol. 127 (11), pp. 1788-1795. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies.
Autorzy :
Choi KY; Department of Otolaryngology Head and Neck Surgery, The Pennsylvania State University, College of Medicine, Hershey, Pennsylvania, U.S.A.
Amit M; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Tam S; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Bell D; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Phan J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Garden AS; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Williams MD; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Ferrarotto R; Department of Thoracic, Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
El-Naggar AK; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Raza SM; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
DeMonte F; Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Kupferman ME; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Hanna EY; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Su SY; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Pokaż więcej
Źródło :
The Laryngoscope [Laryngoscope] 2021 May; Vol. 131 (5), pp. E1468-E1475. Date of Electronic Publication: 2020 Sep 18.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma/*diagnosis
Carcinoma, Neuroendocrine/*diagnosis
Diagnostic Errors/*statistics & numerical data
Maxillary Sinus Neoplasms/*diagnosis
Paranasal Sinus Neoplasms/*diagnosis
Paranasal Sinuses/*pathology
Sarcoma/*diagnosis
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Carcinoma/epidemiology ; Carcinoma/pathology ; Carcinoma/therapy ; Carcinoma, Neuroendocrine/epidemiology ; Carcinoma, Neuroendocrine/pathology ; Carcinoma, Neuroendocrine/therapy ; Child ; Child, Preschool ; Diagnostic Errors/prevention & control ; Female ; Humans ; Incidence ; Kaplan-Meier Estimate ; Male ; Maxillary Sinus Neoplasms/epidemiology ; Maxillary Sinus Neoplasms/pathology ; Maxillary Sinus Neoplasms/therapy ; Middle Aged ; Neoplasm Staging ; Paranasal Sinus Neoplasms/epidemiology ; Paranasal Sinus Neoplasms/pathology ; Paranasal Sinus Neoplasms/therapy ; Referral and Consultation/statistics & numerical data ; Retrospective Studies ; Sarcoma/epidemiology ; Sarcoma/pathology ; Sarcoma/therapy ; Young Adult
SCR Disease Name :
Sinonasal undifferentiated carcinoma
Czasopismo naukowe
Tytuł :
Risk and Clinical Risk Factors Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Squamous Cell Carcinoma Survivors.
Autorzy :
Aggarwal P; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston.; University of Texas School of Public Health, Houston.
Goepfert RP; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston.
Garden AS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston.
Garg N; Department of Abdominal Imaging, University of Texas MD Anderson Cancer Center, Houston.
Zaveri JS; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston.
Du XL; University of Texas School of Public Health, Houston.
Swartz MD; University of Texas School of Public Health, Houston.
Lai SY; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston.
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston.
Ferrarotto R; Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.
Sturgis EM; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
Piller LB; University of Texas School of Public Health, Houston.
Hutcheson KA; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston.; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston.
Pokaż więcej
Źródło :
JAMA otolaryngology-- head & neck surgery [JAMA Otolaryngol Head Neck Surg] 2021 May 01; Vol. 147 (5), pp. 469-478.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cranial Nerve Diseases/*epidemiology
Oropharyngeal Neoplasms/*therapy
Squamous Cell Carcinoma of Head and Neck/*therapy
Adult ; Aged ; Aged, 80 and over ; Cancer Survivors ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Risk Factors ; Texas/epidemiology
Czasopismo naukowe
Tytuł :
Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis.
Autorzy :
Dahlstrom KR; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Song J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Thall PF; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Johnson FM; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; University of Texas Graduate School of Biomedical Sciences, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ferrarotto R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sturgis EM; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Cancer [Cancer] 2021 Apr 15; Vol. 127 (8), pp. 1228-1237. Date of Electronic Publication: 2020 Dec 11.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cancer Survivors*
Oropharyngeal Neoplasms/*mortality
Oropharyngeal Neoplasms/*radiotherapy
Age Factors ; Aged ; Bayes Theorem ; Cause of Death ; Ex-Smokers ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Radiotherapy Dosage ; Radiotherapy, Intensity-Modulated ; Retrospective Studies ; Smokers ; Time Factors ; Tongue Neoplasms/mortality ; Tongue Neoplasms/radiotherapy
Czasopismo naukowe
Tytuł :
Development and validation of a contouring guideline for the taste bud bearing tongue mucosa.
Autorzy :
Stieb S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States. Electronic address: .
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
He R; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Zhu LL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
McDonald BA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Wahid K; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
van Dijk LV; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Ventura J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Ahmed S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
McCoy L; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Deshpande TS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Grant S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Apr; Vol. 157, pp. 63-69. Date of Electronic Publication: 2020 Nov 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Head and Neck Neoplasms*/radiotherapy
Taste Buds*
Humans ; Mouth Mucosa ; Observer Variation ; Tongue
Czasopismo naukowe
Tytuł :
Generating High-Quality Lymph Node Clinical Target Volumes for Head and Neck Cancer Radiation Therapy Using a Fully Automated Deep Learning-Based Approach.
Autorzy :
Cardenas CE; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: .
Beadle BM; Department of Radiation Oncology, Stanford University, Palo Alto, California.
Garden AS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Skinner HD; Department of Radiation Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Yang J; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Rhee DJ; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
McCarroll RE; Department of Radiation Oncology, University of Maryland Medical System, Baltimore, Maryland.
Netherton TJ; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Gay SS; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Zhang L; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Court LE; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2021 Mar 01; Vol. 109 (3), pp. 801-812. Date of Electronic Publication: 2020 Oct 14.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Tomography, X-Ray Computed*/methods
Deep Learning/*standards
Head and Neck Neoplasms/*diagnostic imaging
Lymph Nodes/*diagnostic imaging
Radiotherapy Planning, Computer-Assisted/*methods
Head and Neck Neoplasms/radiotherapy ; Humans ; Pharynx/diagnostic imaging ; Reproducibility of Results ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation.
Autorzy :
Christopherson KM; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Moreno AC; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Elgohari B; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gross N; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mohamed ASR; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Clinical Oncology, University of Alexandria, Alexandria, Egypt.
Brandon Gunn G; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mott FE; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shah SJ; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
David Fuller C; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reddy JP; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: .
Pokaż więcej
Źródło :
Oral oncology [Oral Oncol] 2021 Feb; Vol. 113, pp. 105125. Date of Electronic Publication: 2020 Dec 22.
Typ publikacji :
Journal Article
MeSH Terms :
Oropharyngeal Neoplasms/*drug therapy
Oropharyngeal Neoplasms/*radiotherapy
Papillomavirus Infections/*complications
Salvage Therapy/*methods
Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Oropharyngeal Neoplasms/mortality ; Prognosis ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy.
Autorzy :
Ng SP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. .; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. .
Bahig H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, Centre Hospitalier de l'Universite de Montreal, Montreal, QC, Canada.
Jethanandani A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Johnson FM; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Elgohari B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. .
Pokaż więcej
Źródło :
British journal of cancer [Br J Cancer] 2021 Feb; Vol. 124 (3), pp. 628-633. Date of Electronic Publication: 2020 Oct 14.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Lymphocytes*
Neutrophils*
Carcinoma, Squamous Cell/*blood
Carcinoma, Squamous Cell/*mortality
Oropharyngeal Neoplasms/*blood
Oropharyngeal Neoplasms/*mortality
Adult ; Aged ; Aged, 80 and over ; Analysis of Variance ; Carcinoma, Squamous Cell/radiotherapy ; Carcinoma, Squamous Cell/virology ; Female ; Humans ; Kaplan-Meier Estimate ; Leukocyte Count ; Lymphocyte Count ; Male ; Middle Aged ; Oropharyngeal Neoplasms/radiotherapy ; Oropharyngeal Neoplasms/virology ; Papillomaviridae/isolation & purification ; Prognosis ; Regression Analysis ; Retrospective Studies ; Time Factors
Czasopismo naukowe
Tytuł :
Defining the dose-volume criteria for laryngeal sparing in locally advanced oropharyngeal cancer utilizing split-field IMRT, whole-field IMRT and VMAT.
Autorzy :
Wilke C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Takiar V; Department of Radiation Oncology, University of Cincinnati, Cincinnati, OH, USA.
Wang H; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tung SS; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Quinlan-Davidson SR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wang C; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zhao G; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
Journal of applied clinical medical physics [J Appl Clin Med Phys] 2021 Jan; Vol. 22 (1), pp. 37-44. Date of Electronic Publication: 2020 Dec 05.
Typ publikacji :
Journal Article
MeSH Terms :
Larynx*
Oropharyngeal Neoplasms*/radiotherapy
Radiotherapy, Intensity-Modulated*
Humans ; Organs at Risk ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted
Czasopismo naukowe
Tytuł :
Patient Outcomes after Reirradiation of Small Skull Base Tumors using Stereotactic Body Radiotherapy, Intensity Modulated Radiotherapy, or Proton Therapy.
Autorzy :
Ng SP; Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Wang H; Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Pollard C 3rd; Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Nguyen T; Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Bahig H; Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Fuller CD; Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Gunn GB; Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Garden AS; Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Reddy JP; Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Morrison WH; Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Shah S; Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Rosenthal DI; Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Frank SJ; Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Guha-Thakurta N; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Ferrarotto R; Department of Thoracic Head and Neck Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Hanna EY; Department of Head and Neck Surgery, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Su SY; Department of Head and Neck Surgery, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Phan J; Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, Unites States.
Pokaż więcej
Źródło :
Journal of neurological surgery. Part B, Skull base [J Neurol Surg B Skull Base] 2020 Dec; Vol. 81 (6), pp. 638-644. Date of Electronic Publication: 2019 Jul 31.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Longitudinal characterization of the tumoral microbiome during radiotherapy in HPV-associated oropharynx cancer.
Autorzy :
Bahig H; Radiation Oncology Department, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Radiation Oncology Department, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Fuller CD; Radiation Oncology Department, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mitra A; Radiation Oncology Department, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yoshida-Court K; Radiation Oncology Department, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Solley T; Radiation Oncology Department, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ping Ng S; Radiation Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Australia.
Abu-Gheida I; Radiation Oncology Department, Burjeel Medical City, Abu-Dhabi, United Arab Emirates.
Elgohari B; Radiation Oncology Department, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Clinical Oncology and Nuclear Medicine Department, Mansoura University, Mansoura, Egypt.
Delgado A; Radiation Oncology Department, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Radiation Oncology Department, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Radiation Oncology Department, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Radiation Oncology Department, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reddy JP; Radiation Oncology Department, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Colbert L; Radiation Oncology Department, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Klopp A; Radiation Oncology Department, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2020 Nov 18; Vol. 26, pp. 98-103. Date of Electronic Publication: 2020 Nov 18 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Highly conformal reirradiation in patients with prior oropharyngeal radiation: Clinical efficacy and toxicity outcomes.
Autorzy :
Bagley AF; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Garden AS; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Reddy JP; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Moreno AC; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Shah SJ; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Ferrarotto R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Gross ND; Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Phan J; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2020 Nov; Vol. 42 (11), pp. 3326-3335. Date of Electronic Publication: 2020 Aug 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Head and Neck Neoplasms*/radiotherapy
Radiotherapy, Conformal*/adverse effects
Radiotherapy, Intensity-Modulated*/adverse effects
Re-Irradiation*/adverse effects
Humans ; Neoplasm Recurrence, Local/radiotherapy ; Radiotherapy Dosage ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement.
Autorzy :
Thomson DJ; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, and the Division of Cancer Sciences, The University of Manchester, UK.
Palma D; Division of Radiation Oncology, Western University, London, Canada.
Guckenberger M; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Balermpas P; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Beitler JJ; Department of Radiation Oncology, Emory University, Atlanta, Georgia.
Blanchard P; Department of Radiation Oncology, Gustave Roussy Cancer Center, Villejuif, France.
Brizel D; Department of Radiation Oncology, Duke Cancer Institute, Durham, North Carolina.
Budach W; Department of Radiation Oncology, University Hospital Düsseldorf, Germany.
Caudell J; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida.
Corry J; Department Radiation Oncology Genesiscare, St Vincent's Hospital, Melbourne, Australia.
Corvo R; Department of Radiation Oncology, Ospedale Policlinico San Martino and University, Genoa, Italy.
Evans M; Department of Clinical Oncology, Velindre University NHS Trust, Cardiff, Wales, UK.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Giralt J; Department of Radiation Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Gregoire V; Department of Radiation Oncology, Centre Leon Berard, Lyon, France.
Harari PM; Department of Human Oncology, University of Wisconsin, Madison, Wisconsin.
Harrington K; Division of Radiotherapy and Imaging, Institute for Cancer Research, London, UK.
Hitchcock YJ; Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah.
Johansen J; Department of Oncology, Odense University Hospital, Department of Oncology, Denmark.
Kaanders J; Department of Radiation Oncology, Radboudumc, Nijmegen, The Netherlands.
Koyfman S; Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio.
Langendijk JA; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Le QT; Department of Radiation Oncology, Stanford University, Palo Alto, California.
Lee N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Margalit D; Department of Radiation Oncology, Dana-Farber/Brigham & Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
Mierzwa M; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Porceddu S; Department of Radiation Oncology, Princess Alexandra Hospital, University of Queensland, Brisbane, Australia.
Soong YL; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore.
Sun Y; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.
Thariat J; Department of Radiation Oncology, Centre François Baclesse, University of Normandy, Caen, France.
Waldron J; Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada.
Yom SS; Department of Radiation Oncology, University of California San Francisco, San Francisco, California. Electronic address: .
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2020 Oct; Vol. 151, pp. 314-321. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Outcomes after radiation therapy for T2N0/stage II glottic squamous cell carcinoma.
Autorzy :
Al Feghali KA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Youssef BY; Department of Radiation Oncology, American University of Beirut, Beirut, Lebanon.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Hilal L; Department of Radiation Oncology, American University of Beirut, Beirut, Lebanon.
Smith BD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Abu-Gheida I; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Farha G; Department of Radiation Oncology, St George University Medical Center, Beirut, Lebanon.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Lewin J; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Thekdi A; Department of Otolaryngology, Houston Methodist Hospital, Houston, Texas, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2020 Oct; Vol. 42 (10), pp. 2791-2800. Date of Electronic Publication: 2020 Jun 02.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Head and Neck Neoplasms*
Radiotherapy, Conformal*
Radiotherapy, Intensity-Modulated*
Humans ; Retrospective Studies ; Squamous Cell Carcinoma of Head and Neck/radiotherapy
Czasopismo naukowe
Tytuł :
Outcomes and patterns of radiation associated brain image changes after proton therapy for head and neck skull base cancers.
Autorzy :
Engeseth GM; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Norway; Department of Physics and Technology, University of Bergen, Norway. Electronic address: .
Stieb S; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Mohamed ASR; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
He R; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Stokkevåg CH; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway. Electronic address: .
Brydøy M; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Garden AS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Rosenthal DI; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Phan J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Morrison WH; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Reddy JP; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Wu R; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Zhang X; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Frank SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Brandon Gunn G; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2020 Oct; Vol. 151, pp. 119-125. Date of Electronic Publication: 2020 Jul 15.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Head and Neck Neoplasms*/diagnostic imaging
Head and Neck Neoplasms*/radiotherapy
Proton Therapy*/adverse effects
Brain ; Humans ; Radiotherapy Dosage ; Skull Base
Czasopismo naukowe
Tytuł :
Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
Autorzy :
Elhalawani H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Elgohari B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Lin TA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Sikora AG; ENT Section, Operative Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA.; Bobby R. Alford Department of Otolaryngology Head and Neck Surgery, Baylor College of Medicine, One Baylor Plaza, MS: NA102, Houston, TX, 77030, USA.
Lai SY; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abusaif A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA. .; Medical Physics Program, The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA. .
Sandulache VC; ENT Section, Operative Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. .; Bobby R. Alford Department of Otolaryngology Head and Neck Surgery, Baylor College of Medicine, One Baylor Plaza, MS: NA102, Houston, TX, 77030, USA. .; Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2020 Sep 23; Vol. 20 (1), pp. 912. Date of Electronic Publication: 2020 Sep 23.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Squamous Cell/*etiology
Carcinoma, Squamous Cell/*mortality
Oropharyngeal Neoplasms/*etiology
Oropharyngeal Neoplasms/*mortality
Papillomavirus Infections/*mortality
Smoking/*mortality
Alphapapillomavirus/isolation & purification ; Carcinoma, Squamous Cell/epidemiology ; Carcinoma, Squamous Cell/pathology ; Female ; Humans ; Male ; Middle Aged ; Oropharyngeal Neoplasms/pathology ; Oropharyngeal Neoplasms/virology ; Papillomavirus Infections/pathology ; Retrospective Studies ; Smoking/pathology ; Survival Analysis
Czasopismo naukowe
Tytuł :
SABR for Skull Base Malignancies: A Systematic Analysis of Set-Up and Positioning Accuracy.
Autorzy :
Mesko S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Wang H; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Tung S; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Wang C; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pasalic D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ning MS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pezzi TA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison W; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Su SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hanna E; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: .
Pokaż więcej
Źródło :
Practical radiation oncology [Pract Radiat Oncol] 2020 Sep - Oct; Vol. 10 (5), pp. 363-371. Date of Electronic Publication: 2020 Mar 30.
Typ publikacji :
Journal Article
MeSH Terms :
Skull Base Neoplasms*/diagnostic imaging
Skull Base Neoplasms*/radiotherapy
Cervical Vertebrae ; Cone-Beam Computed Tomography ; Humans ; Radiotherapy Planning, Computer-Assisted ; Radiotherapy Setup Errors ; Skull Base/diagnostic imaging
Czasopismo naukowe
Tytuł :
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials.
Autorzy :
Pasalic D; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
McGinnis GJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Grossberg AJ; Oregon Health & Science University, Portland, OR, USA.
Verma V; Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA.
Mainwaring W; Baylor College of Medicine, Houston, TX, USA.
Miller AB; The University of Texas Health Science Center, McGovern Medical School, Houston, TX, USA.
Lin TA; The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jethanandani A; The University of Tennessee Health Science Center, Memphis, TN, USA.
Espinoza AF; Baylor College of Medicine, Houston, TX, USA.
Diefenhardt M; University of Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany.
Das P; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Subbiah V; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Subbiah IM; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jagsi R; University of Michigan, Ann Arbor, MI, USA.
Garden AS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fokas E; University of Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany; German Cancer Research Center, Heidelberg, Germany; German Cancer Consortium, Frankfurt, Germany.
Rödel C; University of Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany; German Cancer Research Center, Heidelberg, Germany; German Cancer Consortium, Frankfurt, Germany.
Thomas CR Jr; Oregon Health & Science University, Portland, OR, USA.
Minsky BD; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ludmir EB; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: .
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Sep; Vol. 136, pp. 176-185. Date of Electronic Publication: 2020 Jul 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Neoplasms/*diagnosis
Neoplasms/*mortality
Randomized Controlled Trials as Topic/*statistics & numerical data
Biomarkers/analysis ; Clinical Trials, Phase III as Topic/statistics & numerical data ; Comparative Effectiveness Research ; Equivalence Trials as Topic ; Humans ; Neoplasm Metastasis ; Neoplasms/pathology ; Neoplasms/therapy ; Predictive Value of Tests ; Prognosis ; Progression-Free Survival ; Randomized Controlled Trials as Topic/standards ; Research Design ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
A Dosimetric Comparison of Oral Cavity Sparing in the Unilateral Treatment of Early Stage Tonsil Cancer: IMRT, IMPT, and Tongue-Deviating Oral Stents.
Autorzy :
Grant SR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Williamson TD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Stieb S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Shah SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
David Fuller C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cardoso RC; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Liu AY; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Wu RY; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Advances in radiation oncology [Adv Radiat Oncol] 2020 Aug 25; Vol. 5 (6), pp. 1359-1363. Date of Electronic Publication: 2020 Aug 25 (Print Publication: 2020).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer.
Autorzy :
Pasalic D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Betancourt-Cuellar SL; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Taku N; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ludmir EB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lu Y; Department of Radiation Oncology, Ningbo Medical Center, Lihuili Eastern Hospital, Ningbo, China.
Allen PK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Tang C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Antonoff MB; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Welsh JW; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Chang JY; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Liao Z; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Erasmus JJ; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Nguyen QN; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2020 Aug; Vol. 42 (8), pp. 1939-1953. Date of Electronic Publication: 2020 Mar 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Head and Neck Neoplasms*/radiotherapy
Head and Neck Neoplasms*/surgery
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/surgery
Metastasectomy*
Radiosurgery*/adverse effects
Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Neurologic sequelae following radiation with and without chemotherapy for oropharyngeal cancer: Patient reported outcomes study.
Autorzy :
Garden AS; Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, Texas, USA.
Kamal M; Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, Texas, USA.; Department of Clinical Oncology, Ain Shams University, Cairo, Egypt.
Mohamed ASR; Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, Texas, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Frank SJ; Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, Texas, USA.
Lewin JS; Department of Head and Neck Surgery, UT MD Anderson Cancer Center, Houston, Texas, USA.
Lai SY; Department of Head and Neck Surgery, UT MD Anderson Cancer Center, Houston, Texas, USA.
Morrison WH; Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, Texas, USA.
Phan J; Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, Texas, USA.
Ferrarotto R; Department of Thoracic and Head And Neck Medical Oncology, UT MD Anderson Cancer Center, Houston, Texas, USA.
Rosenthal DI; Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, Texas, USA.
Hutcheson KA; Department of Head and Neck Surgery, UT MD Anderson Cancer Center, Houston, Texas, USA.
Fuller CD; Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, Texas, USA.
Gunn GB; Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2020 Aug; Vol. 42 (8), pp. 2137-2144. Date of Electronic Publication: 2020 Mar 25.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Nasopharyngeal Neoplasms*/drug therapy
Oropharyngeal Neoplasms*/therapy
Antineoplastic Combined Chemotherapy Protocols ; Chemoradiotherapy/adverse effects ; Humans ; Induction Chemotherapy ; Nasopharyngeal Carcinoma ; Patient Reported Outcome Measures
Czasopismo naukowe
Tytuł :
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement.
Autorzy :
Thomson DJ; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, and the Division of Cancer Sciences, The University of Manchester, UK.
Palma D; Division of Radiation Oncology, Western University, London, Canada.
Guckenberger M; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Balermpas P; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Beitler JJ; Department of Radiation Oncology, Emory University, Atlanta, Georgia.
Blanchard P; Department of Radiation Oncology, Gustave Roussy Cancer Center, Villejuif, France.
Brizel D; Department of Radiation Oncology, Duke Cancer Institute, Durham, North Carolina.
Budach W; Department of Radiation Oncology, University Hospital Düsseldorf, Germany.
Caudell J; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida.
Corry J; Department Radiation Oncology Genesiscare, St Vincent's Hospital, Melbourne, Australia.
Corvo R; Department of Radiation Oncology, Ospedale Policlinico San Martino and University, Genoa, Italy.
Evans M; Department of Clinical Oncology, Velindre University NHS Trust, Cardiff, Wales, UK.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Giralt J; Department of Radiation Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Gregoire V; Department of Radiation Oncology, Centre Leon Berard, Lyon, France.
Harari PM; Department of Human Oncology, University of Wisconsin, Madison, Wisconsin.
Harrington K; Division of Radiotherapy and Imaging, Institute for Cancer Research, London, UK.
Hitchcock YJ; Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah.
Johansen J; Department of Oncology, Odense University Hospital, Department of Oncology, Denmark.
Kaanders J; Department of Radiation Oncology, Radboudumc, Nijmegen, The Netherlands.
Koyfman S; Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio.
Langendijk JA; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Le QT; Department of Radiation Oncology, Stanford University, Palo Alto, California.
Lee N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Margalit D; Department of Radiation Oncology, Dana-Farber/Brigham & Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
Mierzwa M; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Porceddu S; Department of Radiation Oncology, Princess Alexandra Hospital, University of Queensland, Brisbane, Australia.
Soong YL; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore.
Sun Y; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.
Thariat J; Department of Radiation Oncology, Centre François Baclesse, University of Normandy, Caen, France.
Waldron J; Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada.
Yom SS; Department of Radiation Oncology, University of California San Francisco, San Francisco, California. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Jul 15; Vol. 107 (4), pp. 618-627. Date of Electronic Publication: 2020 Apr 14.
Typ publikacji :
Journal Article
MeSH Terms :
Consensus*
Medical Oncology*
Pandemics*
Practice Guidelines as Topic*
Societies, Medical*
Coronavirus Infections/*epidemiology
Head and Neck Neoplasms/*radiotherapy
Pneumonia, Viral/*epidemiology
COVID-19 ; Humans
Czasopismo naukowe
Tytuł :
Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8 Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results.
Autorzy :
Ferrarotto R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. .
Bell D; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rubin ML; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Johnson JM; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Elamin YY; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Torman DK; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Warneke CL; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hessel AC; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Myers JN; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Johnson FM; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; The University of Texas MD Anderson Cancer Center Graduate School of Biomedical Sciences, Houston, Texas.
Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sikora AG; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
Gillison ML; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Glisson BS; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gross ND; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jul 01; Vol. 26 (13), pp. 3211-3219. Date of Electronic Publication: 2020 Apr 08.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Lymphocyte Count*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
CD8-Positive T-Lymphocytes/*drug effects
CD8-Positive T-Lymphocytes/*immunology
Oropharyngeal Neoplasms/*drug therapy
Oropharyngeal Neoplasms/*immunology
Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Biomarkers, Tumor ; CD8-Positive T-Lymphocytes/metabolism ; CD8-Positive T-Lymphocytes/pathology ; Disease Progression ; Female ; Humans ; Immunohistochemistry ; Male ; Neoadjuvant Therapy ; Oropharyngeal Neoplasms/mortality ; Oropharyngeal Neoplasms/pathology ; Quality of Life ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
A prospective parallel design study testing non-inferiority of customized oral stents made using 3D printing or manually fabricated methods.
Autorzy :
Zaid M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Koay EJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States. Electronic address: .
Bajaj N; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Mathew R; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Xiao L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Agrawal A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Fernandes P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Burrows H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Roach MA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Wilke CT; Department of Radiation Oncology, University of Minnesota Medical School, 516 Delaware St SE, Minneapolis, MN 55455, United States.
Chung C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Andersen M; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Otun A; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Chambers MS; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Pokaż więcej
Źródło :
Oral oncology [Oral Oncol] 2020 Jul; Vol. 106, pp. 104665. Date of Electronic Publication: 2020 Apr 13.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Head and Neck Neoplasms/*surgery
Printing, Three-Dimensional/*instrumentation
Stents/*standards
Adult ; Aged ; Female ; Head and Neck Neoplasms/radiotherapy ; Humans ; Male ; Middle Aged ; Prospective Studies
Czasopismo naukowe
Tytuł :
Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer.
Autorzy :
Grant SR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, United States.
Ye R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, United States.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Brandon Gunn G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Lewin JS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, United States.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, United States.
Ferrarotto R; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States. Electronic address: .
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2020 Jul; Vol. 148, pp. 133-139. Date of Electronic Publication: 2020 Apr 21.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Deglutition Disorders*/etiology
Oropharyngeal Neoplasms*/radiotherapy
Proton Therapy*/adverse effects
Radiotherapy, Intensity-Modulated*/adverse effects
Deglutition ; Humans ; Patient Reported Outcome Measures ; Prospective Studies
Czasopismo naukowe
Tytuł :
Patient-reported outcomes, physician-reported toxicities, and treatment outcomes in a modern cohort of patients with sinonasal cancer treated using proton beam therapy.
Autorzy :
Pasalic D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Ludmir EB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Allen PK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Thaker NG; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Chapman BV; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Su SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Ferrarotto R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Glisson BS; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Brandon Gunn G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States. Electronic address: .
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2020 Jul; Vol. 148, pp. 258-266. Date of Electronic Publication: 2020 May 15.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Neoplasms*
Physicians*
Proton Therapy*/adverse effects
Humans ; Patient Reported Outcome Measures ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors.
Autorzy :
Stieb S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Perez-Martinez I; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Rock S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Bajaj N; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Deshpande TS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Zaid M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Cardoso R; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Ferrarotto R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Koay EJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Pokaż więcej
Corporate Authors :
MD Anderson Head and Neck Cancer Symptom Working Group
Źródło :
Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2020 Jun 09; Vol. 24, pp. 71-78. Date of Electronic Publication: 2020 Jun 09 (Print Publication: 2020).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Patterns of Failure After Intensity Modulated Radiation Therapy in Head and Neck Squamous Cell Carcinoma of Unknown Primary: Implication of Elective Nodal and Mucosal Dose Coverage.
Autorzy :
Kamal M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.; MD Anderson Cancer Center/UTHealth Graduate School of Biomedical Sciences, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; MD Anderson Cancer Center/UTHealth Graduate School of Biomedical Sciences, Houston, Texas.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Johnson FM; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; The University of Texas Graduate School of Biomedical Sciences, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Volpe S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; European Institute of Oncology IRCCS, Division of Radiation Oncology, Milano, Italy.
Ng SP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Rice University, Houston, Texas.
Cardenas C; Department of Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ferrarotto R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Advances in radiation oncology [Adv Radiat Oncol] 2020 May 15; Vol. 5 (5), pp. 929-935. Date of Electronic Publication: 2020 May 15 (Print Publication: 2020).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Comparison of tumor delineation using dual energy computed tomography versus magnetic resonance imaging in head and neck cancer re-irradiation cases.
Autorzy :
Ng SP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
Cardenas CE; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Elhalawani H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pollard C 3rd; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Elgohari B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fang P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Meheissen M; Department of Clinical Oncology and Nuclear Medicine, University of Alexandria, Alexandria, Egypt.
Guha-Thakurta N; Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Bahig H; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Johnson JM; Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kamal M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Su SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Brandon Gunn G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
Physics and imaging in radiation oncology [Phys Imaging Radiat Oncol] 2020 Apr 29; Vol. 14, pp. 1-5. Date of Electronic Publication: 2020 Apr 29 (Print Publication: 2020).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Lymphopenia during radiotherapy in patients with oropharyngeal cancer.
Autorzy :
Ng SP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. Electronic address: .
Bahig H; Department of Radiation Oncology, Centre Hospitalier de l'Universite de Montreal, Canada.
Jethanandani A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Pollard C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Berends J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA.
Johnson FM; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Elgohari B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Elhalawani H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Skinner HD; Department of Radiation Oncology, UPMC Hillman Cancer Centers, Pittsburgh, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2020 Apr; Vol. 145, pp. 95-100. Date of Electronic Publication: 2020 Jan 10.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Lymphopenia*/etiology
Oropharyngeal Neoplasms*/radiotherapy
Humans ; Lymphocytes ; Middle Aged ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: Potential for improvement over time?
Autorzy :
Stieb S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Deshpande TS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Harp J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Greiner B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Cardoso R; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Ferrarotto R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Brandon Gunn G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States.
Pokaż więcej
Corporate Authors :
MD Anderson Head and Neck Cancer Symptom Working Group
Źródło :
Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2020 Mar 24; Vol. 22, pp. 98-105. Date of Electronic Publication: 2020 Mar 24 (Print Publication: 2020).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A prospective evaluation of health-related quality of life after skull base re-irradiation.
Autorzy :
Bahig H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ng SP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pollard C 3rd; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Nguyen TP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ferrarotto R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
DeMonte F; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Su SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2020 Mar; Vol. 42 (3), pp. 485-497. Date of Electronic Publication: 2019 Dec 23.
Typ publikacji :
Journal Article
MeSH Terms :
Quality of Life*
Re-Irradiation*
Humans ; Prospective Studies ; Skull Base ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: A partially observed Markov decision process model.
Autorzy :
Ng SP; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
Ajayi T; Department of Computational and Applied Mathematics, Rice University, Houston, Texas.
Schaefer AJ; Department of Computational and Applied Mathematics, Rice University, Houston, Texas.
Pollard C 3rd; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Bahig H; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Garden AS; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Johnson JM; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mohamed ASR; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sturgis EM; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Feb 15; Vol. 126 (4), pp. 749-756. Date of Electronic Publication: 2019 Nov 14.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Markov Chains*
Carcinoma, Squamous Cell/*radiotherapy
Head and Neck Neoplasms/*radiotherapy
Monitoring, Physiologic/*methods
Algorithms ; Carcinoma, Squamous Cell/diagnostic imaging ; Cohort Studies ; Female ; Head and Neck Neoplasms/diagnostic imaging ; Humans ; Magnetic Resonance Imaging/methods ; Male ; Middle Aged ; Models, Biological ; Neoplasm Recurrence, Local ; Tomography, X-Ray Computed/methods
Czasopismo naukowe
Tytuł :
Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial.
Autorzy :
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 97, Houston, TX, 77030, USA. .
Mendoza TR; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 97, Houston, TX, 77030, USA.
Wang XS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shi Q; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 97, Houston, TX, 77030, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 97, Houston, TX, 77030, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 97, Houston, TX, 77030, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 97, Houston, TX, 77030, USA.
Chambers MS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lu C; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 97, Houston, TX, 77030, USA.
Cleeland CS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2020 Jan; Vol. 28 (1), pp. 261-269. Date of Electronic Publication: 2019 Apr 29.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Head and Neck Neoplasms/*drug therapy
Head and Neck Neoplasms/*radiotherapy
Minocycline/*therapeutic use
Radiodermatitis/*prevention & control
Aged ; Combined Modality Therapy ; Deglutition Disorders/epidemiology ; Deglutition Disorders/etiology ; Fatigue/epidemiology ; Fatigue/etiology ; Female ; Head and Neck Neoplasms/epidemiology ; Humans ; Male ; Middle Aged ; Pain/epidemiology ; Pain/etiology ; Sleep Wake Disorders/epidemiology ; Sleep Wake Disorders/etiology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation.
Autorzy :
Mohamed ASR; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.; Department of Clinical Oncology, University of Alexandria, Alexandria, Egypt.
Smith BD; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.; University of Texas McGovern Medical School, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas, U.S.A.
Smith JB; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.; University of Texas McGovern Medical School, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas, U.S.A.
Sevak P
Malek JS
Kanwar A
Browne T
Gunn GB; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Garden AS; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Frank SJ; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Morrison WH; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Phan J; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Zafereo M; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Skinner H; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Lewin JS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Hessel AE; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Thekdi AA; Department of Otolaryngology, Houston Methodist Hospital, Houston, Texas, U.S.A.
Weber RS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Fuller CD; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.; Medical Physics Program, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas, U.S.A.
Rosenthal DI; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Pokaż więcej
Źródło :
The Laryngoscope [Laryngoscope] 2020 Jan; Vol. 130 (1), pp. 146-153. Date of Electronic Publication: 2019 Feb 12.
Typ publikacji :
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Glottis*
Carcinoma, Squamous Cell/*radiotherapy
Laryngeal Neoplasms/*radiotherapy
Radiotherapy, Intensity-Modulated/*methods
Carcinoma, Squamous Cell/pathology ; Carotid Arteries ; Case-Control Studies ; Female ; Humans ; Laryngeal Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Organ Sparing Treatments ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Estimating PTV Margins in Head and Neck Stereotactic Ablative Radiation Therapy (SABR) Through Target Site Analysis of Positioning and Intrafractional Accuracy.
Autorzy :
Mesko S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Wang H; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Tung S; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Wang C; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pasalic D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Chapman BV; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison W; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Jan 01; Vol. 106 (1), pp. 185-193. Date of Electronic Publication: 2019 Sep 30.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Radiotherapy Setup Errors*
Head and Neck Neoplasms/*radiotherapy
Neoplasm Recurrence, Local/*radiotherapy
Radiosurgery/*methods
Aged ; Cone-Beam Computed Tomography/methods ; Dose Fractionation, Radiation ; Head and Neck Neoplasms/diagnostic imaging ; Head and Neck Neoplasms/pathology ; Humans ; Immobilization/methods ; Middle Aged ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/pathology ; Parotid Neoplasms/diagnostic imaging ; Parotid Neoplasms/radiotherapy ; Patient Positioning ; Prospective Studies ; Quality Improvement ; Radiotherapy Planning, Computer-Assisted/methods ; Radiotherapy, Image-Guided/methods ; Re-Irradiation/methods ; Skull Base Neoplasms/diagnostic imaging ; Skull Base Neoplasms/radiotherapy
Czasopismo naukowe
Tytuł :
Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy.
Autorzy :
Bagley AF; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Ye R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Sturgis EM; Department of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA.
Ferrarotto R; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Wu R; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, USA.
Liu AY; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2020 Jan; Vol. 142, pp. 133-139. Date of Electronic Publication: 2019 Aug 17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Oropharyngeal Neoplasms/*radiotherapy
Proton Therapy/*methods
Radiation Injuries/*etiology
Xerostomia/*etiology
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Parotid Gland/radiation effects ; Quality of Life ; Radiation Injuries/physiopathology ; Radiation Injuries/psychology ; Retrospective Studies ; Xerostomia/physiopathology ; Xerostomia/psychology
Czasopismo naukowe
Tytuł :
Not All 30-Gy Regimens Are Equal.
Autorzy :
Garden AS; Adam S. Garden, MD, University of Texas MD Anderson Cancer Center, Houston, TX.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Dec 20; Vol. 37 (36), pp. 3558-3559. Date of Electronic Publication: 2019 Sep 26.
Typ publikacji :
Letter; Comment
MeSH Terms :
Carcinoma, Squamous Cell*
Papillomaviridae*
Papillomavirus Infections*
Chemoradiotherapy, Adjuvant ; Humans ; Oropharynx ; Radiotherapy Dosage
Opinia redakcyjna
Tytuł :
Automatic detection of contouring errors using convolutional neural networks.
Autorzy :
Rhee DJ; The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX, 77030, USA.; Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Cardenas CE; Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Elhalawani H; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
McCarroll R; Department of Radiation Oncology, The University of Maryland Medical System, Baltimore, MD, 21201, USA.
Zhang L; Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Yang J; Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Garden AS; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Peterson CB; Department of Biostatistics, Division of Basic Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Beadle BM; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Court LE; Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Pokaż więcej
Źródło :
Medical physics [Med Phys] 2019 Nov; Vol. 46 (11), pp. 5086-5097. Date of Electronic Publication: 2019 Sep 26.
Typ publikacji :
Journal Article
MeSH Terms :
Neural Networks, Computer*
Tomography, X-Ray Computed*
Image Processing, Computer-Assisted/*methods
Automation ; Humans ; Neoplasms/diagnostic imaging ; Neoplasms/radiotherapy
Czasopismo naukowe
Tytuł :
Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer.
Autorzy :
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Warneke CL; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Yao CMKL; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Zaveri J; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Elgohari BE; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Goepfert R; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hessel AC; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kupferman ME; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Johnson F; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ferrarotto R; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lewin JS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gross ND; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Corporate Authors :
MD Anderson Head and Neck Cancer Symptom Working Group
Źródło :
JAMA otolaryngology-- head & neck surgery [JAMA Otolaryngol Head Neck Surg] 2019 Nov 01; Vol. 145 (11), pp. 1053-1063.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy.
Autorzy :
Ng SP; 1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.; 2Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria Australia.
Pollard C 3rd; 1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Kamal M; 1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Ayoub Z; 1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Garden AS; 1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Bahig H; 1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Gunn GB; 1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Frank SJ; 1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Skinner HD; 1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Phan J; 1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Berends J; 3The University of Texas Health Science Center, San Antonio, TX USA.
Morrison WH; 1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Johnson JM; 4Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Ferrarotto R; 5Department of Thoracic Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Sturgis EM; 6Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Mohamed ASR; 1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Lai SY; 6Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Fuller CD; 1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Rosenthal DI; 1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Pokaż więcej
Źródło :
NPJ precision oncology [NPJ Precis Oncol] 2019 Sep 27; Vol. 3, pp. 22. Date of Electronic Publication: 2019 Sep 27 (Print Publication: 2019).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Creating customized oral stents for head and neck radiotherapy using 3D scanning and printing.
Autorzy :
Zaid M; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Bajaj N; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Burrows H; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Mathew R; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Dai A; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Wilke CT; Department of Radiation Oncology, University of Minnesota Medical School, 516 Delaware St SE, Minneapolis, MN, 55455, USA.
Palasi S; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Hergenrother R; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Chung C; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Fuller CD; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Phan J; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Gunn GB; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Morrison WH; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Garden AS; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Frank SJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Rosenthal DI; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Andersen M; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Otun A; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Chambers MS; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Koay EJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA. .
Pokaż więcej
Źródło :
Radiation oncology (London, England) [Radiat Oncol] 2019 Aug 19; Vol. 14 (1), pp. 148. Date of Electronic Publication: 2019 Aug 19.
Typ publikacji :
Journal Article
MeSH Terms :
Stents*
Head and Neck Neoplasms/*radiotherapy
Printing, Three-Dimensional/*instrumentation
Radiotherapy Planning, Computer-Assisted/*methods
Radiotherapy, Intensity-Modulated/*instrumentation
Tomography, X-Ray Computed/*methods
Adult ; Aged ; Dental Impression Technique ; Dental Models ; Female ; Head and Neck Neoplasms/diagnostic imaging ; Head and Neck Neoplasms/pathology ; Humans ; Male ; Middle Aged ; Prognosis ; Radiotherapy Dosage ; Reproducibility of Results ; Retrospective Studies ; Workflow
Czasopismo naukowe
Tytuł :
The role of salvage surgery with interstitial brachytherapy for the Management of Regionally Recurrent Head and Neck Cancers.
Autorzy :
Khan N; 1Baylor College of Medicine, Houston, TX USA.
Clemens M; 2Department of Plastic Surgery, University of Texas M. D. Anderson Cancer Center, Houston, TX USA.
Liu J; 2Department of Plastic Surgery, University of Texas M. D. Anderson Cancer Center, Houston, TX USA.
Garden AS; 3Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX USA.
Lawyer A; 3Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX USA.
Weber R; 4Department of Head and Neck Surgery, University of Texas M. D. Anderson Cancer Center, Unit 441, 1515 Holcombe Boulevard, Houston, TX 77096 USA.
Gunn GB; 3Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX USA.
Morrison WH; 3Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX USA.
Kupferman ME; 4Department of Head and Neck Surgery, University of Texas M. D. Anderson Cancer Center, Unit 441, 1515 Holcombe Boulevard, Houston, TX 77096 USA.
Pokaż więcej
Źródło :
Cancers of the head & neck [Cancers Head Neck] 2019 Jul 22; Vol. 4, pp. 4. Date of Electronic Publication: 2019 Jul 22 (Print Publication: 2019).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient Care.
Autorzy :
Ning MS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gomez DR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Proton Therapy Center, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Shah AK; Proton Therapy Center, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kim CR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Palmer MB; Proton Therapy Center, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Thaker NG; Department of Radiation Oncology, Arizona Oncology, The US Oncology Network, Tucson, Arizona.
Grosshans DR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Proton Therapy Center, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Liao Z; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Proton Therapy Center, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Chapman BV; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Brooks ED; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Tang C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Proton Therapy Center, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Proton Therapy Center, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Proton Therapy Center, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Proton Therapy Center, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Proton Therapy Center, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2019 Jul 15; Vol. 104 (4), pp. 724-733. Date of Electronic Publication: 2018 Dec 14.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Head and Neck Neoplasms/*radiotherapy
Insurance Claim Review/*statistics & numerical data
Insurance Coverage/*statistics & numerical data
Insurance, Health, Reimbursement/*statistics & numerical data
Proton Therapy/*economics
Thoracic Neoplasms/*radiotherapy
Time-to-Treatment/*statistics & numerical data
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Medicare/statistics & numerical data ; Middle Aged ; Prior Authorization/statistics & numerical data ; Proton Therapy/statistics & numerical data ; Randomized Controlled Trials as Topic/statistics & numerical data ; Regression Analysis ; Retrospective Studies ; United States ; Young Adult
Czasopismo naukowe
Tytuł :
Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.
Autorzy :
Ng SP; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pollard C 3rd; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Berends J; The University of Texas Health Science Center, San Antonio, Texas.
Ayoub Z; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kamal M; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Clinical Oncology, Ain Shams University, Cairo, Egypt.
Garden AS; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Bahig H; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cantor SB; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Schaefer AJ; Department of Computational and Applied Mathematics, Rice University, Houston, Texas.
Ajayi T; Department of Computational and Applied Mathematics, Rice University, Houston, Texas.
Gunn GB; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Skinner H; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ferrarotto R; Division of Cancer Medicine, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Johnson JM; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mohamed ASR; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lai SY; Division of Surgery, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hessel AC; Division of Surgery, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sturgis EM; Division of Surgery, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Weber RS; Division of Surgery, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Cancer [Cancer] 2019 Jun 01; Vol. 125 (11), pp. 1823-1829. Date of Electronic Publication: 2019 Feb 12.
Typ publikacji :
Journal Article
MeSH Terms :
Head and Neck Neoplasms/*diagnostic imaging
Head and Neck Neoplasms/*epidemiology
Neoplasm Recurrence, Local/*diagnostic imaging
Neoplasm Recurrence, Local/*epidemiology
Population Surveillance/*methods
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Early Detection of Cancer ; Female ; Head and Neck Neoplasms/radiotherapy ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/radiotherapy ; Retrospective Studies ; Salvage Therapy ; Survival Analysis ; Time-to-Treatment ; Young Adult
Czasopismo naukowe
Tytuł :
Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
Autorzy :
Lin TA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Baylor College of Medicine, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Elhalawani H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Elgohari B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Jethanandani A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ng SP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mohamed AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Glisson BS; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Debnam JM; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Skinner HD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Cancer [Cancer] 2019 May 01; Vol. 125 (9), pp. 1536-1546. Date of Electronic Publication: 2019 Jan 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Squamous Cell/*diagnosis
Carcinoma, Squamous Cell/*pathology
Lymph Nodes/*diagnostic imaging
Oropharyngeal Neoplasms/*diagnosis
Oropharyngeal Neoplasms/*pathology
Papillomavirus Infections/*diagnosis
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell/therapy ; Carcinoma, Squamous Cell/virology ; Cervical Vertebrae/diagnostic imaging ; Chemoradiotherapy/statistics & numerical data ; Cohort Studies ; Female ; Head and Neck Neoplasms/diagnosis ; Head and Neck Neoplasms/pathology ; Head and Neck Neoplasms/therapy ; Head and Neck Neoplasms/virology ; Humans ; Lymph Nodes/pathology ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Staging ; Oropharyngeal Neoplasms/therapy ; Oropharyngeal Neoplasms/virology ; Papillomavirus Infections/complications ; Papillomavirus Infections/epidemiology ; Papillomavirus Infections/therapy ; Pharynx/diagnostic imaging ; Prognosis ; Retrospective Studies ; Squamous Cell Carcinoma of Head and Neck/diagnosis ; Squamous Cell Carcinoma of Head and Neck/pathology ; Squamous Cell Carcinoma of Head and Neck/therapy ; Squamous Cell Carcinoma of Head and Neck/virology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Optimizing laryngeal sparing with intensity modulated radiotherapy or volumetric modulated arc therapy for unilateral tonsil cancer.
Autorzy :
Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wilke C; Department of Radiation Oncology, The University of Minnesota, Minneapolis, MN, USA.
Wang H; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tung SS; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pollard C 3rd; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shah SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Takiar V; Department of Radiation Oncology at the University of Cincinnati, Cincinnati, OH, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
Physics and imaging in radiation oncology [Phys Imaging Radiat Oncol] 2019 May 01; Vol. 10, pp. 29-34. Date of Electronic Publication: 2019 May 01 (Print Publication: 2019).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Patient-reported outcomes of symptom burden in patients receiving surgical or nonsurgical treatment for low-intermediate risk oropharyngeal squamous cell carcinoma: A comparative analysis of a prospective registry.
Autorzy :
Amit M; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hutcheson K; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zaveri J; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lewin J; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kupferman ME; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hessel AC; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Goepfert RP; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Brandon Gunn G; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferraratto R; Department of Thoracic/Head and Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dave Fuller C; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tam S; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gross ND; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: .
Pokaż więcej
Źródło :
Oral oncology [Oral Oncol] 2019 Apr; Vol. 91, pp. 13-20. Date of Electronic Publication: 2019 Feb 16.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Patient Reported Outcome Measures*
Carcinoma, Squamous Cell/*therapy
Oropharyngeal Neoplasms/*therapy
Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Prospective Studies ; Registries
Czasopismo naukowe
Tytuł :
Postoperative Radiation Therapy for Metastatic Cervical Adenopathy.
Autorzy :
Garden AS; Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, TX. Electronic address: .
Reddy JP; Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, TX.
Pokaż więcej
Źródło :
Seminars in radiation oncology [Semin Radiat Oncol] 2019 Apr; Vol. 29 (2), pp. 144-149.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Radiotherapy, Adjuvant*
Carcinoma, Squamous Cell/*radiotherapy
Head and Neck Neoplasms/*radiotherapy
Lymphatic Metastasis/*radiotherapy
Carcinoma, Squamous Cell/surgery ; Head and Neck Neoplasms/surgery ; Humans ; Lymph Node Excision ; Neck Dissection ; Neoplasm Recurrence, Local ; Radiotherapy Dosage ; Risk Factors
Czasopismo naukowe
Tytuł :
Development and validation of a 3D-printed bolus cap for total scalp irradiation.
Autorzy :
Baltz GC; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medical Physics Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
Chi PM; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medical Physics Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
Wong PF; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wang C; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medical Physics Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
Craft DF; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medical Physics Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
Kry SF; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medical Physics Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
Lin SSH; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Smith SA; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Howell RM; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medical Physics Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
Pokaż więcej
Źródło :
Journal of applied clinical medical physics [J Appl Clin Med Phys] 2019 Mar; Vol. 20 (3), pp. 89-96. Date of Electronic Publication: 2019 Mar 01.
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
Phantoms, Imaging*
Carcinoma, Squamous Cell/*radiotherapy
Printing, Three-Dimensional/*instrumentation
Scalp/*radiation effects
Skin Neoplasms/*radiotherapy
Aged ; Humans ; Male ; Radiometry ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted/methods ; Radiotherapy, Intensity-Modulated
Czasopismo naukowe
Tytuł :
Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
Autorzy :
Moreno AC; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn GB; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reddy JP; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Williamson TD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Holliday EB; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Blanchard P; Department of Radiation Oncology, Gustave Roussy, Villejuif, France. Electronic address: .
Pokaż więcej
Źródło :
Oral oncology [Oral Oncol] 2019 Jan; Vol. 88, pp. 66-74. Date of Electronic Publication: 2018 Nov 21.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Head and Neck Neoplasms/*mortality
Head and Neck Neoplasms/*therapy
Proton Therapy/*methods
Radiotherapy, Intensity-Modulated/*methods
Humans ; Photons/adverse effects ; Photons/therapeutic use ; Proton Therapy/adverse effects ; Radiodermatitis/etiology ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted ; Radiotherapy, Intensity-Modulated/adverse effects ; Retreatment ; Stomatitis/etiology ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Author Correction: Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy.
Autorzy :
Grossberg AJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA. .; Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon, 97238, USA. .
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, 21321, Egypt.
Elhalawani H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Bennett WC; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, USA.
Smith KE; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, USA.
Nolan TS; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, USA.
Williams B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Chamchod S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.; Radiation Oncology Unit, Chulabhorn Hospital, Bangkok, 10210, Thailand.
Heukelom J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.; Department of Radiation Oncology, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
Kantor ME; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Browne T; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Freymann JB; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, 20892, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA. .
Pokaż więcej
Źródło :
Scientific data [Sci Data] 2018 Nov 27; Vol. 5 (1), pp. 1. Date of Electronic Publication: 2018 Nov 27.
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
Significance of Negative Posttreatment 18-FDG PET/CT Imaging in Patients With p16/HPV-Positive Oropharyngeal Cancer.
Autorzy :
Ng SP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Johnson JM; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Skinner HD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison W; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mott FE; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Williams MD; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2018 Nov 15; Vol. 102 (4), pp. 1029-1035. Date of Electronic Publication: 2018 Jun 28.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Fluorodeoxyglucose F18*
Positron Emission Tomography Computed Tomography*
Cyclin-Dependent Kinase Inhibitor p16/*metabolism
Oropharyngeal Neoplasms/*diagnostic imaging
Oropharyngeal Neoplasms/*virology
Papillomaviridae/*physiology
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Oropharyngeal Neoplasms/metabolism ; Oropharyngeal Neoplasms/therapy ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Auto-delineation of oropharyngeal clinical target volumes using 3D convolutional neural networks.
Autorzy :
Cardenas CE; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Author to whom any correspondence should be addressed.
Anderson BM
Aristophanous M
Yang J
Rhee DJ
McCarroll RE
Mohamed ASR
Kamal M
Elgohari BA
Elhalawani HM
Fuller CD
Rao A
Garden AS
Court LE
Pokaż więcej
Źródło :
Physics in medicine and biology [Phys Med Biol] 2018 Nov 07; Vol. 63 (21), pp. 215026. Date of Electronic Publication: 2018 Nov 07.
Typ publikacji :
Journal Article
MeSH Terms :
Neural Networks, Computer*
Image Processing, Computer-Assisted/*methods
Oropharyngeal Neoplasms/*pathology
Oropharyngeal Neoplasms/*radiotherapy
Radiotherapy Planning, Computer-Assisted/*methods
Tomography, X-Ray Computed/*methods
Humans ; Oropharyngeal Neoplasms/diagnostic imaging ; Radiotherapy Dosage ; Radiotherapy, Intensity-Modulated ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Decreased gastrostomy tube incidence and weight loss after transoral robotic surgery for low- to intermediate-risk oropharyngeal squamous cell carcinoma.
Autorzy :
Heah H; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Otolaryngology, Singapore General Hospital, Singapore.
Goepfert RP; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Hutcheson KA; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Lewin JS; Department of Otolaryngology, Singapore General Hospital, Singapore.
Kupferman ME; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Holsinger FC; Department of Otolaryngology - Head and Neck Surgery, Stanford University Medical Center, Stanford, California.
Hessel AC; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Gross ND; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2018 Nov; Vol. 40 (11), pp. 2507-2513. Date of Electronic Publication: 2018 Aug 13.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Weight Loss*
Carcinoma, Squamous Cell/*surgery
Enteral Nutrition/*statistics & numerical data
Gastrostomy/*statistics & numerical data
Oropharyngeal Neoplasms/*surgery
Robotic Surgical Procedures/*methods
Adult ; Aged ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Chemoradiotherapy/methods ; Cohort Studies ; Enteral Nutrition/methods ; Female ; Follow-Up Studies ; Gastrostomy/methods ; Humans ; Incidence ; Male ; Middle Aged ; Multivariate Analysis ; Natural Orifice Endoscopic Surgery/methods ; Oropharyngeal Neoplasms/mortality ; Oropharyngeal Neoplasms/pathology ; Quality Improvement ; Regression Analysis ; Retrospective Studies ; Risk Assessment ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling.
Autorzy :
Ng SP; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. .
Bahig H; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Wang J; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cardenas CE; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lucci A; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hall CS; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Meas S; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sarli VN; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yuan Y; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Urbauer DL; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ding Y; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ikner S; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Dinh V; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Elgohari BA; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Johnson JM; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Skinner HD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Gunn GB; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Garden AS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Phan J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Rosenthal DI; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Morrison WH; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Frank SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Hutcheson KA; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mohamed ASR; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Lai SY; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
MacManus MP; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2018 Sep 19; Vol. 18 (1), pp. 903. Date of Electronic Publication: 2018 Sep 19.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Protocols*
Magnetic Resonance Imaging*/methods
Head and Neck Neoplasms/*diagnosis
Neoplastic Cells, Circulating/*pathology
Biomarkers ; Female ; Head and Neck Neoplasms/therapy ; Humans ; Image Processing, Computer-Assisted/methods ; Imaging, Three-Dimensional ; Liquid Biopsy ; Male ; Positron Emission Tomography Computed Tomography ; Positron-Emission Tomography ; Prognosis ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy.
Autorzy :
Grossberg AJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.; Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon 97238, USA.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, 21321 Egypt.
Elhalawani H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Bennett WC; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
Smith KE; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
Nolan TS; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
Williams B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Chamchod S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.; Radiation Oncology Unit, Chulabhorn Hospital, Bangkok 10210, Thailand.
Heukelom J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.; Department of Radiation Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Kantor ME; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Browne T; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Freymann JB; Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, Maryland 20892, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Pokaż więcej
Źródło :
Scientific data [Sci Data] 2018 Sep 04; Vol. 5, pp. 180173. Date of Electronic Publication: 2018 Sep 04.
Typ publikacji :
Dataset; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Head and Neck Neoplasms*/diagnostic imaging
Head and Neck Neoplasms*/radiotherapy
Squamous Cell Carcinoma of Head and Neck*/diagnostic imaging
Squamous Cell Carcinoma of Head and Neck*/radiotherapy
Humans ; Image Processing, Computer-Assisted ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Age-adjusted comorbidity and survival in locally advanced laryngeal cancer.
Autorzy :
Mulcahy CF; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
Kanwar A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ghosh A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Vock D; Department of Biostatistics, University of Minnesota of Public Health, Minneapolis, Minnesota.
Weber RS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Zafereo M; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ferrarotto R; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Corporate Authors :
Multidisciplinary Larynx Cancer Working Group
Źródło :
Head & neck [Head Neck] 2018 Sep; Vol. 40 (9), pp. 2060-2069. Date of Electronic Publication: 2018 May 13.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Laryngeal Neoplasms/*complications
Laryngeal Neoplasms/*mortality
Adult ; Age Factors ; Aged ; Aged, 80 and over ; Comorbidity ; Disease-Free Survival ; Female ; Humans ; Laryngeal Neoplasms/pathology ; Male ; Middle Aged ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial.
Autorzy :
Bahig H; University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Yuan Y; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mohamed ASR; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Brock KK; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ng SP; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wang J; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ding Y; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hutcheson K; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
McCulloch M; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Balter PA; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lai SY; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Al-Mamgani A; Netherlands Cancer Institute, Amsterdam, Netherlands.
Sonke JJ; Netherlands Cancer Institute, Amsterdam, Netherlands.
van der Heide UA; Netherlands Cancer Institute, Amsterdam, Netherlands.
Nutting C; Royal Marsden NHS Foundation Trust, London, UK.
Li XA; Medical College of Wisconsin, Milwaukee, WI, USA.
Robbins J; Medical College of Wisconsin, Milwaukee, WI, USA.
Awan M; Medical College of Wisconsin, Milwaukee, WI, USA.
Karam I; Sunnybrook Health Sciences Centre, Toronto, Canada.
Newbold K; Institute of Cancer Research, London, UK.
Harrington K; Institute of Cancer Research, London, UK.
Oelfke U; Institute of Cancer Research, London, UK.
Bhide S; Royal Marsden NHS Foundation Trust, London, UK.
Philippens MEP; University Medical Center Utrecht, Utrecht, Netherlands.
Terhaard CHJ; University Medical Center Utrecht, Utrecht, Netherlands.
McPartlin AJ; The Christie NHS Foundation Trust, Manchester, UK.
Blanchard P; Gustave-Roussy, Villejuif, France.
Garden AS; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn GB; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cazoulat G; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Aristophanous M; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
McSpadden KK; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garcia JA; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
van den Berg CAT; University Medical Center Utrecht, Utrecht, Netherlands.
Raaijmakers CPJ; University Medical Center Utrecht, Utrecht, Netherlands.
Kerkmeijer L; University Medical Center Utrecht, Utrecht, Netherlands.
Doornaert P; VU University Medical Center, de Boelelaan, Netherlands.
Blinde S; Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Frank SJ; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2018 Aug 24; Vol. 13, pp. 19-23. Date of Electronic Publication: 2018 Aug 24 (Print Publication: 2018).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma.
Autorzy :
Cabanillas ME; 1 Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, Texas.
Ferrarotto R; 2 Department of Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center , Houston, Texas.
Garden AS; 3 Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, Texas.
Ahmed S; 4 Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center , Houston, Texas.
Busaidy NL; 1 Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, Texas.
Dadu R; 1 Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, Texas.
Williams MD; 5 Department of Pathology, The University of Texas MD Anderson Cancer Center , Houston, Texas.
Skinner H; 3 Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, Texas.
Gunn GB; 3 Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, Texas.
Grosu H; 6 Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center , Houston, Texas.
Iyer P; 1 Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, Texas.
Hofmann MC; 1 Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, Texas.
Zafereo M; 7 Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center , Houston, Texas.
Pokaż więcej
Źródło :
Thyroid : official journal of the American Thyroid Association [Thyroid] 2018 Jul; Vol. 28 (7), pp. 945-951. Date of Electronic Publication: 2018 Jun 29.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antibodies, Monoclonal, Humanized/*therapeutic use
Antineoplastic Agents, Immunological/*therapeutic use
Proto-Oncogene Proteins B-raf/*genetics
Thyroid Carcinoma, Anaplastic/*drug therapy
Thyroid Neoplasms/*drug therapy
Humans ; Male ; Middle Aged ; Neoadjuvant Therapy ; Thyroid Carcinoma, Anaplastic/genetics ; Thyroid Carcinoma, Anaplastic/pathology ; Thyroid Neoplasms/genetics ; Thyroid Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT.
Autorzy :
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.; MD Anderson Cancer Center/UT Health Graduate School of Biomedical Sciences, Houston, TX, USA.
Bahig H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, Centre hospitalier de l'Université de Montréal (CHUM), Canada.
Aristophanous M; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Blanchard P; Department of Radiation Oncology, Institut de Cancérologie Gustave Roussy, Paris, France.
Kamal M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Ain Shams, Cairo, Egypt.
Ding Y; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cardenas CE; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Brock KK; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wang J; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ibbott G; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gabr RE; Department of Diagnostic & Interventional Imaging, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Narayana PA; Department of Diagnostic & Interventional Imaging, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Corporate Authors :
MD Anderson MRLinac Development Working Group
Źródło :
Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2018 May 05; Vol. 11, pp. 11-18. Date of Electronic Publication: 2018 May 05 (Print Publication: 2018).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Stereotactic radiosurgery for trigeminal pain secondary to recurrent malignant skull base tumors.
Autorzy :
Phan J; Departments of1Radiation Oncology.
Pollard C; Departments of1Radiation Oncology.
Brown PD; 6Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.
Guha-Thakurta N; 5Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, Texas; and.
Garden AS; Departments of1Radiation Oncology.
Rosenthal DI; Departments of1Radiation Oncology.
Fuller CD; Departments of1Radiation Oncology.
Frank SJ; Departments of1Radiation Oncology.
Gunn GB; Departments of1Radiation Oncology.
Morrison WH; Departments of1Radiation Oncology.
Ho JC; Departments of1Radiation Oncology.
Li J; Departments of1Radiation Oncology.
Ghia AJ; Departments of1Radiation Oncology.
Yang JN; 4Radiation Physics, and.
Luo D; 4Radiation Physics, and.
Wang HC; 4Radiation Physics, and.
Su SY; 3Head and Neck Surgery.
Raza SM; 2Neurosurgery.
Gidley PW; 3Head and Neck Surgery.
Hanna EY; 3Head and Neck Surgery.
DeMonte F; 2Neurosurgery.
Pokaż więcej
Źródło :
Journal of neurosurgery [J Neurosurg] 2018 Apr 27; Vol. 130 (3), pp. 812-821.
Typ publikacji :
Journal Article
MeSH Terms :
Radiosurgery/*methods
Skull Base Neoplasms/*complications
Trigeminal Neuralgia/*etiology
Trigeminal Neuralgia/*surgery
Adult ; Aged ; Aged, 80 and over ; Analgesics, Opioid/therapeutic use ; Breakthrough Pain/drug therapy ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neck Pain/etiology ; Neck Pain/surgery ; Neoplasm Recurrence, Local ; Pain Measurement ; Palliative Care ; Radiation Dosage ; Steroids/therapeutic use ; Treatment Outcome ; Trigeminal Neuralgia/drug therapy
Czasopismo naukowe
Tytuł :
Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer.
Autorzy :
Kamal M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Ng SP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Eraj SA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; School of Medicine, The University of Texas Health Science Center at Houston, McGovern School of Medicine, Houston, TX, USA.
Rock CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; School of Medicine, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, TX, USA.
Pham B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Messer JA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Radiation Oncology, The University of Texas Medical Branch, Galveston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
El-Naggar AK; Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
Johnson JM; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ginsberg LE; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lewin JS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cardenas CE; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, USA.
Zafereo ME; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hessel AC; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Weber RS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Cancer Biology Program, The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Cancer Biology Program, The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt. Electronic address: .
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: .
Pokaż więcej
Źródło :
Oral oncology [Oral Oncol] 2018 Apr; Vol. 79, pp. 1-8. Date of Electronic Publication: 2018 Feb 10.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Chemoradiotherapy*
Neoplasm Invasiveness*
Laryngeal Neoplasms/*diagnostic imaging
Laryngeal Neoplasms/*therapy
Vocal Cords/*pathology
Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Humans ; Laryngeal Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Recurrence, Local ; Prognosis ; Survival Analysis
Czasopismo naukowe
Tytuł :
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation.
Autorzy :
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: .
Blanchard P; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.
Kies MS; Department of Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Machtay M; Department of Radiation Oncology, UH Cleveland Medical Center, Cleveland, OH.
Vikram B; Clinical Radiation Oncology Branch, National Cancer Institute, Bethesda, MD.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Hutcheson K; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.
Lai S; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.
Busse PM; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA.
Lee NY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Lin A; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.
Foote RL; Department of Radiation Oncology, The Mayo Clinic, Rochester, MN.
Pokaż więcej
Źródło :
Seminars in radiation oncology [Semin Radiat Oncol] 2018 Apr; Vol. 28 (2), pp. 108-113.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Randomized Controlled Trials as Topic*
Research Design*
Oropharyngeal Neoplasms/*radiotherapy
Photons/*therapeutic use
Proton Therapy/*methods
Radiotherapy, Intensity-Modulated/*methods
Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic ; Disease-Free Survival ; Endpoint Determination ; Female ; Humans ; Male ; Neoplasm Staging ; Organs at Risk/radiation effects ; Oropharyngeal Neoplasms/pathology ; Quality of Life ; Radiation Injuries/prevention & control ; Radiotherapy Dosage ; Texas
Czasopismo naukowe
Tytuł :
Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy.
Autorzy :
Kamal M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Johnson FM; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; The University of Texas Graduate School of Biomedical Sciences, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Volpe S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; University of Milan, Department of Oncology and Hemato-Oncology, University of Milan, Milano, Italy.
Ng SP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ferrarotto R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Skinner HD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Cancer [Cancer] 2018 Apr 01; Vol. 124 (7), pp. 1415-1427. Date of Electronic Publication: 2018 Jan 16.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Squamous Cell/*mortality
Head and Neck Neoplasms/*mortality
Neoplasms, Unknown Primary/*mortality
Radiotherapy, Intensity-Modulated/*mortality
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell/radiotherapy ; Carcinoma, Squamous Cell/secondary ; Female ; Follow-Up Studies ; Head and Neck Neoplasms/radiotherapy ; Head and Neck Neoplasms/secondary ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasms, Unknown Primary/pathology ; Neoplasms, Unknown Primary/radiotherapy ; Prognosis ; Radiotherapy Dosage ; Retrospective Studies ; Survival Rate ; Young Adult
Czasopismo naukowe
Tytuł :
In Regard to Routman et al.
Autorzy :
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2018 Apr 01; Vol. 100 (5), pp. 1295-1296.
Typ publikacji :
Letter; Comment
MeSH Terms :
Neoplasm Recurrence, Local*
Papillomaviridae*
Epithelial Cells ; Humans ; Radiotherapy Dosage
Opinia redakcyjna
Tytuł :
Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors.
Autorzy :
Kamal M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Volpe S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; University of Milan, Department of Oncology and Hemato-Oncology, Milano, Italy.
Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA.
Al Feghali KA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; The Naef K. Basile Cancer Institute at the American University of Beirut Medical Center, Lebanon.
Meheissen MAM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Egypt.
Eraj SA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; School of Medicine, The University of Texas Health Science Center at Houston, McGovern School of Medicine, USA.
Dursteler AE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; School of Medicine, The University of Texas Health Science Center at Houston, McGovern School of Medicine, USA.
Williams B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Smith JB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; School of Medicine, The University of Texas Health Science Center at Houston, McGovern School of Medicine, USA.
Aymard JM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Abilene Christian University, USA.
Berends J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; University of Texas Health Science Center at San Antono, USA.
White AL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; School of Medicine, The University of Texas Health Science Center at Houston, McGovern School of Medicine, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Cardoso R; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA.
Chambers MS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Epidemiology, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, USA.
Mendoza TR; Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
Lu C; Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Egypt; MD Anderson Cancer Center/UTHealth Graduate School of Biomedical Sciences, Houston, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; MD Anderson Cancer Center/UTHealth Graduate School of Biomedical Sciences, Houston, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Pokaż więcej
Corporate Authors :
MD Anderson Head and Neck Cancer Symptom Working Group
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2018 Jan; Vol. 126 (1), pp. 75-80. Date of Electronic Publication: 2017 Dec 08.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Head and Neck Neoplasms/*radiotherapy
Radiation Injuries/*diagnosis
Radiation Injuries/*etiology
Xerostomia/*diagnosis
Xerostomia/*etiology
Adult ; Aged ; Aged, 80 and over ; Bayes Theorem ; Cancer Survivors ; Cohort Studies ; Female ; Head and Neck Neoplasms/physiopathology ; Humans ; Male ; Middle Aged ; Quality of Life ; Self Report ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
In Regard to Sher et al.
Autorzy :
Walker GV; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, Banner MD Anderson, Gilbert, Arizona.
Blanchard P; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
Garden AS; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Practical radiation oncology [Pract Radiat Oncol] 2018 Jan - Feb; Vol. 8 (1), pp. 66-67. Date of Electronic Publication: 2017 Aug 05.
Typ publikacji :
Letter; Comment
MeSH Terms :
Breast Neoplasms*
Receptor, ErbB-2*
Humans
Opinia redakcyjna
Tytuł :
Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old.
Autorzy :
Eraj SA; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; School of Medicine, The University of Texas Health Science Center at Houston, McGovern School of Medicine, Houston, TX, USA.
Jomaa MK; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Rock CD; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; School of Medicine, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, TX, USA.
Mohamed ASR; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Smith BD; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; School of Medicine, The University of Texas Health Science Center at Houston, McGovern School of Medicine, Houston, TX, USA.
Smith JB; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; School of Medicine, The University of Texas Health Science Center at Houston, McGovern School of Medicine, Houston, TX, USA.
Browne T; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Cooksey LC; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Abilene Christian University, Abilene, TX, USA.
Williams B; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Temple B; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Abilene Christian University, Abilene, TX, USA.
Preston KE; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Abilene Christian University, Abilene, TX, USA.
Aymard JM; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Abilene Christian University, Abilene, TX, USA.
Gross ND; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Weber RS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hessel AC; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Epidemiology, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Neurosurgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Morrison WH; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Mendoza TR; Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cleeland CS; Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Medical Physics Program, The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Brandon Gunn G; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. .; Department of Neurosurgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. .
Pokaż więcej
Corporate Authors :
MD Anderson Head and Neck Cancer Symptom Working Group
Źródło :
Radiation oncology (London, England) [Radiat Oncol] 2017 Nov 23; Vol. 12 (1), pp. 186. Date of Electronic Publication: 2017 Nov 23.
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
Atlas ranking and selection for automatic segmentation of the esophagus from CT scans.
Autorzy :
Yang J; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States of America.
Haas B
Fang R
Beadle BM
Garden AS
Liao Z
Zhang L
Balter P
Court L
Pokaż więcej
Źródło :
Physics in medicine and biology [Phys Med Biol] 2017 Nov 14; Vol. 62 (23), pp. 9140-9158. Date of Electronic Publication: 2017 Nov 14.
Typ publikacji :
Journal Article
MeSH Terms :
Tomography, X-Ray Computed*
Esophagus/*diagnostic imaging
Image Processing, Computer-Assisted/*methods
Algorithms ; Automation ; Head and Neck Neoplasms/diagnostic imaging ; Head and Neck Neoplasms/radiotherapy ; Humans ; Male ; Radiotherapy Planning, Computer-Assisted ; Radiotherapy, Intensity-Modulated
Czasopismo naukowe
Tytuł :
Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer.
Autorzy :
Jensen GL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Blanchard P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
David Fuller C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gillison ML; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2017 Nov 06; Vol. 7, pp. 28-35. Date of Electronic Publication: 2017 Nov 06 (Print Publication: 2017).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis.
Autorzy :
Pollard C 3rd; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Nguyen TP; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Ng SP; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Beadle BM; Department of Radiation Oncology, Stanford University, Stanford, California.
Morrison WH; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Shah SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Wang H; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Tung S; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Wang C; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Ginsberg LD; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Zafereo ME; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Sturgis EM; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Su SY; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Hanna EY; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2017 Oct; Vol. 39 (10), pp. 2079-2087. Date of Electronic Publication: 2017 Jul 25.
Typ publikacji :
Journal Article
MeSH Terms :
Head and Neck Neoplasms/*radiotherapy
Radiotherapy, Conformal/*methods
Re-Irradiation/*methods
Combined Modality Therapy ; Female ; Head and Neck Neoplasms/pathology ; Humans ; Lymph Nodes/pathology ; Lymphatic Metastasis ; Male ; Neoplasm Recurrence, Local ; Proton Therapy/adverse effects ; Proton Therapy/methods ; Radiosurgery/adverse effects ; Radiosurgery/methods ; Radiotherapy, Conformal/adverse effects ; Re-Irradiation/adverse effects ; Retrospective Studies ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Cognitive function and patient-reported memory problems after radiotherapy for cancers at the skull base: A cross-sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory-Head and Neck Module.
Autorzy :
Hansen CC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Texas Tech University Health Sciences Center, School of Medicine, Lubbock, Texas.
Smith JB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; University of Texas Medical School at Houston, Houston, Texas.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Clinical Oncology, University of Alexandria, Alexandria, Egypt.
Mulcahy CF; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Otolaryngology - Head and Neck Surgery, George Washington University, Washington, DC.
Wefel JS; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Chrane K; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; School of Allied Health Sciences/Physician Assistant Program, Baylor College of Medicine, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Smith BD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; University of Texas Medical School at Houston, Houston, Texas.
Eichelberger H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; University of Texas Medical School at Houston, Houston, Texas.
Anderson C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; University of Texas, Austin, Texas.
McCoy C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Texas Tech University Health Sciences Center, School of Medicine, Lubbock, Texas.
Horiates M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Yale University, New Haven, Connecticut.
Patrick C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; University of Texas, Austin, Texas.
Floris S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Abilene Christian University, Abilene, Texas.
French C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; University of Texas Medical School at Houston, Houston, Texas.
Beadle BM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Su SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lewis CM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kupferman ME; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Johnson JM; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Skinner HD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Medical Physics Program, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Corporate Authors :
MD Anderson Head and Neck Cancer Symptom Working Group
Źródło :
Head & neck [Head Neck] 2017 Oct; Vol. 39 (10), pp. 2048-2056. Date of Electronic Publication: 2017 Aug 01.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
MeSH Terms :
Cognitive Dysfunction/*diagnosis
Memory Disorders/*diagnosis
Skull Base/*pathology
Skull Base Neoplasms/*radiotherapy
Adolescent ; Adult ; Aged ; Area Under Curve ; Central Nervous System/radiation effects ; Cognition ; Cognitive Dysfunction/epidemiology ; Cognitive Dysfunction/etiology ; Cross-Sectional Studies ; Female ; Health Status Indicators ; Humans ; Interviews as Topic/methods ; Male ; Mass Screening/methods ; Memory Disorders/epidemiology ; Memory Disorders/etiology ; Middle Aged ; Patient Reported Outcome Measures ; Radiation Injuries/diagnosis ; Severity of Illness Index ; Survivorship ; Young Adult
Czasopismo naukowe
Tytuł :
Transoral Robotic Surgery-Assisted Endoscopy.
Autorzy :
Garden AS; Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
JAMA otolaryngology-- head & neck surgery [JAMA Otolaryngol Head Neck Surg] 2017 Oct 01; Vol. 143 (10), pp. 1058-1059.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Endoscopy*
Robotic Surgical Procedures*
Czasopismo naukowe
Tytuł :
Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old.
Autorzy :
Eraj SA; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; School of Medicine, The University of Texas Health Science Center at Houston, McGovern School of Medicine, Houston, TX, USA.
Jomaa MK; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Rock CD; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; School of Medicine, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, TX, USA.
Mohamed ASR; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Smith BD; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; School of Medicine, The University of Texas Health Science Center at Houston, McGovern School of Medicine, Houston, TX, USA.
Smith JB; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; School of Medicine, The University of Texas Health Science Center at Houston, McGovern School of Medicine, Houston, TX, USA.
Browne T; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Cooksey LC; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Abilene Christian University, Abilene, TX, USA.
Williams B; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Temple B; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Abilene Christian University, Abilene, TX, USA.
Preston KE; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Abilene Christian University, Abilene, TX, USA.
Aymard JM; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Abilene Christian University, Abilene, TX, USA.
Gross ND; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Weber RS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hessel AC; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Epidemiology, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Neurosurgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Morrison WH; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Mendoza TR; Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cleeland CS; Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Medical Physics Program, The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Gunn GB; Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. .; Department of Neurosurgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. .
Pokaż więcej
Corporate Authors :
MD Anderson Head and Neck Cancer Symptom Working Group
Źródło :
Radiation oncology (London, England) [Radiat Oncol] 2017 Sep 09; Vol. 12 (1), pp. 150. Date of Electronic Publication: 2017 Sep 09.
Typ publikacji :
Journal Article
MeSH Terms :
Oropharyngeal Neoplasms/*radiotherapy
Radiotherapy/*adverse effects
Aged ; Aged, 80 and over ; Cross-Sectional Studies ; Female ; Humans ; Male ; Patient Reported Outcome Measures ; Prospective Studies ; Surveys and Questionnaires ; Time ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Outcomes of oral cavity cancer patients treated with surgery followed by postoperative intensity modulated radiation therapy.
Autorzy :
Quinlan-Davidson SR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Radiation Oncology, Allentown Radiation Oncology Associates, Allentown, PA, USA.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Myers JN; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Johnson FM; Department of Thoracic/Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA.
Skinner H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Beadle BM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gillenwater AM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
William WN; Department of Thoracic/Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wong AJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: .
Pokaż więcej
Źródło :
Oral oncology [Oral Oncol] 2017 Sep; Vol. 72, pp. 90-97. Date of Electronic Publication: 2017 Jul 16.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Radiotherapy, Intensity-Modulated*
Carcinoma, Squamous Cell/*radiotherapy
Carcinoma, Squamous Cell/*surgery
Mouth Neoplasms/*radiotherapy
Mouth Neoplasms/*surgery
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell/pathology ; Combined Modality Therapy ; Female ; Humans ; Male ; Middle Aged ; Mouth Neoplasms/pathology ; Postoperative Care ; Retrospective Studies ; Survival Rate ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Patterns of locoregional failure following post-operative intensity-modulated radiotherapy to oral cavity cancer: quantitative spatial and dosimetric analysis using a deformable image registration workflow.
Autorzy :
Mohamed ASR; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. .; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt. .
Wong AJ; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Fuller CD; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Kamal M; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Ain-Shams, Cairo, Egypt.
Gunn GB; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Phan J; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Morrison WH; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Beadle BM; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Skinner H; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Quinlan-Davidson SR; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Department of Radiation Oncology, Allentown Radiation Oncology Associates, Allentown, PA, USA.
Belal AM; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
El-Gowily AG; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Frank SJ; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Rosenthal DI; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Garden AS; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. .
Pokaż więcej
Źródło :
Radiation oncology (London, England) [Radiat Oncol] 2017 Aug 15; Vol. 12 (1), pp. 129. Date of Electronic Publication: 2017 Aug 15.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasm Recurrence, Local*
Carcinoma, Squamous Cell/*radiotherapy
Head and Neck Neoplasms/*radiotherapy
Mouth Neoplasms/*radiotherapy
Radiotherapy, Intensity-Modulated/*methods
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Radiometry ; Radiotherapy, Adjuvant/methods ; Retrospective Studies ; Squamous Cell Carcinoma of Head and Neck ; Young Adult
Czasopismo naukowe
Tytuł :
Delayed lower cranial neuropathy after oropharyngeal intensity-modulated radiotherapy: A cohort analysis and literature review.
Autorzy :
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Yuk M; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hubbard R; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lin H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kies MS; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lewin JS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2017 Aug; Vol. 39 (8), pp. 1516-1523. Date of Electronic Publication: 2017 Apr 28.
Typ publikacji :
Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Radiation Injuries*
Cranial Nerve Diseases/*etiology
Oropharyngeal Neoplasms/*radiotherapy
Radiotherapy, Intensity-Modulated/*adverse effects
Cohort Studies ; Cranial Nerve Diseases/epidemiology ; Datasets as Topic ; Humans ; Incidence ; Kaplan-Meier Estimate ; Oropharyngeal Neoplasms/mortality ; Radiotherapy, Intensity-Modulated/methods ; Time Factors
Czasopismo naukowe
Tytuł :
Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
Autorzy :
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: .
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
El-Naggar AK; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kamal M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, Ain Shams University, Cairo, Egypt.
Weber RS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Peters LJ; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2017 Aug 01; Vol. 98 (5), pp. 1002-1011. Date of Electronic Publication: 2017 Jul 10.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms :
Carcinoma, Squamous Cell/*radiotherapy
Head and Neck Neoplasms/*radiotherapy
Adult ; Aged ; Aged, 80 and over ; Analysis of Variance ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/surgery ; Dose-Response Relationship, Radiation ; Female ; Head and Neck Neoplasms/mortality ; Head and Neck Neoplasms/pathology ; Head and Neck Neoplasms/surgery ; Humans ; Hypopharyngeal Neoplasms/mortality ; Hypopharyngeal Neoplasms/pathology ; Hypopharyngeal Neoplasms/radiotherapy ; Hypopharyngeal Neoplasms/surgery ; Kaplan-Meier Estimate ; Laryngeal Neoplasms/mortality ; Laryngeal Neoplasms/pathology ; Laryngeal Neoplasms/radiotherapy ; Laryngeal Neoplasms/surgery ; Male ; Margins of Excision ; Middle Aged ; Mouth Neoplasms/mortality ; Mouth Neoplasms/pathology ; Mouth Neoplasms/radiotherapy ; Mouth Neoplasms/surgery ; Oropharyngeal Neoplasms/mortality ; Oropharyngeal Neoplasms/pathology ; Oropharyngeal Neoplasms/radiotherapy ; Oropharyngeal Neoplasms/surgery ; Postoperative Care ; Prospective Studies ; Radiotherapy/adverse effects ; Radiotherapy Dosage ; Survival Rate ; Time Factors
Czasopismo naukowe
Tytuł :
Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions.
Autorzy :
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Egypt.
Cardenas CE; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Awan MJ; Department of Radiation Oncology, Case Western Reserve University, Cleveland, USA.
Rock CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Westergaard SA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Brandon Gunn G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Belal AM; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Egypt.
El-Gowily AG; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Egypt.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Aristophanous M; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2017 Aug; Vol. 124 (2), pp. 248-255. Date of Electronic Publication: 2017 Jul 31.
Typ publikacji :
Journal Article
MeSH Terms :
Fluorodeoxyglucose F18*
Radiopharmaceuticals*
Head and Neck Neoplasms/*diagnostic imaging
Head and Neck Neoplasms/*radiotherapy
Positron Emission Tomography Computed Tomography/*methods
Radiotherapy Planning, Computer-Assisted/*methods
Adult ; Aged ; Aged, 80 and over ; Dose-Response Relationship, Radiation ; Female ; Head and Neck Neoplasms/pathology ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/radiotherapy ; Positron-Emission Tomography/methods ; Tomography, X-Ray Computed/methods ; Treatment Failure ; Tumor Burden
Czasopismo naukowe
Tytuł :
Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx.
Autorzy :
Shiao JC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Messer JA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, The University of Texas Medical Branch, Galveston, Texas.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Johnson JM; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Enderling H; Integrated Mathematical Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Kamal M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Ain Shams, Cairo, Egypt.
Warren BW; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pham B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Zafereo ME; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hessel AC; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kies MS; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ferrarotto R; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Schomer DF; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Beadle BM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Weber RS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lewin JS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Medical Physics Program, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2017 Aug; Vol. 39 (8), pp. 1609-1620. Date of Electronic Publication: 2017 May 02.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Tumor Burden*
Carcinoma, Squamous Cell/*pathology
Laryngeal Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell/diagnostic imaging ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/therapy ; Combined Modality Therapy ; Cone-Beam Computed Tomography ; Female ; Humans ; Laryngeal Neoplasms/diagnostic imaging ; Laryngeal Neoplasms/mortality ; Laryngeal Neoplasms/therapy ; Laryngectomy ; Larynx/diagnostic imaging ; Larynx/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Radiotherapy ; Retrospective Studies ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy.
Autorzy :
Cardenas CE; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Tao R; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Wong AJR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Awan MJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kuruvila S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Aristophanous M; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Beadle BM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: .
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2017 Jul 01; Vol. 98 (3), pp. 532-540. Date of Electronic Publication: 2016 Nov 19.
Typ publikacji :
Journal Article; Observational Study; Research Support, N.I.H., Extramural
MeSH Terms :
Clinical Competence*
Head and Neck Neoplasms/*radiotherapy
Peer Review/*methods
Physical Examination/*methods
Quality Assurance, Health Care/*methods
Radiation Oncology/*standards
Radiotherapy Planning, Computer-Assisted/*methods
Radiotherapy, Intensity-Modulated/*methods
Adult ; Aged ; Cancer Care Facilities/standards ; Evaluation Studies as Topic ; Female ; Follow-Up Studies ; Head and Neck Neoplasms/diagnostic imaging ; Head and Neck Neoplasms/pathology ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Recurrence, Local/epidemiology ; Physical Examination/standards ; Prospective Studies ; Qualitative Research ; Quality Assurance, Health Care/standards ; Radiotherapy Planning, Computer-Assisted/standards ; Radiotherapy, Intensity-Modulated/standards ; Statistics, Nonparametric ; Teaching Rounds ; Texas ; Time Factors ; Tomography, Emission-Computed ; Treatment Failure ; Tumor Burden
Czasopismo naukowe
Tytuł :
ECOG-ACRIN 1308: Commentary on a Negative Phase II Trial.
Autorzy :
Garden AS; Adam S. Garden and Pierre Blanchard, The University of Texas MD Anderson Cancer Center, Houston, TX.
Blanchard P; Adam S. Garden and Pierre Blanchard, The University of Texas MD Anderson Cancer Center, Houston, TX.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2017 Jun 10; Vol. 35 (17), pp. 1969-1970. Date of Electronic Publication: 2017 Apr 21.
Typ publikacji :
Letter; Comment
MeSH Terms :
Carcinoma, Squamous Cell*
Papillomavirus Infections*
Cetuximab ; Humans ; Induction Chemotherapy ; Oropharynx
Opinia redakcyjna
Tytuł :
Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.
Autorzy :
Zhang W; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Zhang X; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Yang P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Blanchard P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Gunn B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Chambers M; Department of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA.
Hutcheson KA; Department of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA.
Ye R; Department of Quantitative Research, The University of Texas MD Anderson Cancer Center, Houston, USA.
Lai SY; Department of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA.
Radwan MAS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Egypt.
Zhu XR; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2017 Jun; Vol. 123 (3), pp. 401-405. Date of Electronic Publication: 2017 May 23.
Typ publikacji :
Journal Article
MeSH Terms :
Oropharyngeal Neoplasms/*radiotherapy
Osteoradionecrosis/*etiology
Proton Therapy/*adverse effects
Radiotherapy, Intensity-Modulated/*adverse effects
Adult ; Aged ; Female ; Humans ; Male ; Mandible/radiation effects ; Middle Aged ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted/methods
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies